A retrospective pooled analysis assessing the effect of age on the immunogenicity of Havrix™ in healthy adults

Over recent decades, the global incidence of hepatitis A virus infection has been reduced by improvements in sanitation infrastructure and through immunization programs. The immunogenicity and field efficacy of the inactivated hepatitis A vaccine (Havrix™, GSK, Belgium) has been demonstrated in clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Der Meeren, Olivier, Crasta, Priya, de Ridder, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2015
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514304/
https://www.ncbi.nlm.nih.gov/pubmed/26029816
http://dx.doi.org/10.1080/21645515.2015.1045167

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514304/
https://www.ncbi.nlm.nih.gov/pubmed/26029816
http://dx.doi.org/10.1080/21645515.2015.1045167

Ejemplares similares